Literature DB >> 28186386

Investigating self-efficacy, disease knowledge and adherence to treatment in adolescents with cystic fibrosis.

Nicholas R Faint1, Janelle M Staton1, Stephen M Stick2, Juliet M Foster3, André Schultz2,4.   

Abstract

AIM: Patient adherence is integral to the effectiveness of prescribed treatment, and is associated with beneficial disease outcomes, yet in adolescents with cystic fibrosis, adherence is often sub-optimal. Multiple factors may contribute to treatment adherence, including disease knowledge and self-efficacy. In adolescents with cystic fibrosis: (i) to compare the disease knowledge of adolescents and their parents before transition to adult care; (ii) to determine the relationship between disease knowledge (adolescent, parent) and adherence; and (iii) to evaluate self-efficacy and its association with disease knowledge and adherence.
METHODS: Adolescents with cystic fibrosis and their parents were recruited from a tertiary children's hospital. Disease knowledge and self-efficacy was assessed using the Knowledge of Disease Management-CF and General Self-Efficacy Scales respectively. Using pharmacy records, medication possession ratio was calculated to measure treatment adherence in the preceding year.
RESULTS: Thirty-nine adolescent (aged 12-17 (median 14) years) and parent pairs were recruited. Adherence to hypertonic saline, but not other medications, was significantly associated with disease knowledge in adolescents (r 2  = 0.40, P = 0.029). Mean (SD) adolescent self-efficacy was 30.8 (4.0), and not associated with disease knowledge or adherence. Mean (SD) disease knowledge was less in adolescents than parents (55 (16)% and 72 (14)% respectively, P < 0.001).
CONCLUSION: Disease knowledge is sub-optimal in adolescents with cystic fibrosis, even in the 2 years immediately before transition to adult care. Given that adherence with some treatments has been associated with disease knowledge our results suggest the need for educational interventions in adolescents with cystic fibrosis to optimise self-management and health outcomes.
© 2017 Paediatrics and Child Health Division (The Royal Australasian College of Physicians).

Entities:  

Keywords:  adolescent; cystic fibrosis; disease knowledge; self-efficacy; treatment adherence

Mesh:

Substances:

Year:  2017        PMID: 28186386     DOI: 10.1111/jpc.13458

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  6 in total

1.  Greater number of perceived barriers to hydroxyurea associated with poorer health-related quality of life in youth with sickle cell disease.

Authors:  Arlene Smaldone; Deepa Manwani; Nancy S Green
Journal:  Pediatr Blood Cancer       Date:  2019-04-02       Impact factor: 3.167

Review 2.  The future of cystic fibrosis care: a global perspective.

Authors:  Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2019-09-27       Impact factor: 30.700

Review 3.  Transition to adulthood and adult health care for patients with sickle cell disease or cystic fibrosis: Current practices and research priorities.

Authors:  Sophie Lanzkron; Gregory S Sawicki; Kathryn L Hassell; Michael W Konstan; Robert I Liem; Susanna A McColley
Journal:  J Clin Transl Sci       Date:  2018-10

4.  Adherence to long-term therapies in cystic fibrosis: a French cross-sectional study linking prescribing, dispensing, and hospitalization data.

Authors:  Héloïse Rouzé; Marie Viprey; Samuel Allemann; Alexandra L Dima; Pascal Caillet; Angélique Denis; Stéphanie Poupon-Bourdy; Boubou Camara; Catherine Llerena; Philippe Reix; Isabelle Durieu; Quitterie Reynaud; Sandrine Touzet
Journal:  Patient Prefer Adherence       Date:  2019-09-04       Impact factor: 2.711

5.  Translation, cross-cultural adaptation and psychometric evaluation of the Brazilian version of the Cystic Fibrosis Knowledge Scale (CFKS).

Authors:  Karolinne Souza Monteiro; Thayla Amorim Santino; Smita Pakhale; Louise Balfour; Karla Morganna Pereira Pinto de Mendonça
Journal:  PLoS One       Date:  2021-11-16       Impact factor: 3.240

Review 6.  Refill Adherence Measures and Its Association with Economic, Clinical, and Humanistic Outcomes Among Pediatric Patients: A Systematic Review.

Authors:  Brandon Chua; James Morgan; Kai Zhen Yap
Journal:  Int J Environ Res Public Health       Date:  2020-03-23       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.